Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 51 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,338 followers.

Nice reviews by Wolters et al. (https://t.co/UgpiIncFRU) & @GinusB et al. (https://t.co/IRNFmHBGO5) on the first generation and second generation tau PET tracers and the future work remaining to be done.

22 Feb 2021

Reply Repost Favourite

RT @RikOssenkoppele: Led by @Ginus, we also determined the maturity of "second-generation" #tau #PET tracers like MK6240, RO948 and PI2620.…

17 Feb 2021

Reply Repost Favourite

RT @RikOssenkoppele: Led by @Ginus, we also determined the maturity of "second-generation" #tau #PET tracers like MK6240, RO948 and PI2620.…

17 Feb 2021

Reply Repost Favourite

Led by @Ginus, we also determined the maturity of "second-generation" #tau #PET tracers like MK6240, RO948 and PI2620. As expected, they are less advanced compared to flortaucipir PET on the road to clinical validity, but important progress has been made:

17 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.